Functional validation identified LCN2 as a critical immunomodulator, rescuing inflammatory imbalance via regulating ANXA1/Arginase‐1 expression, thus highlighting its therapeutic potential in degenerative disc disease. This evidence concerns the gene LCN2 and intervertebral disk degenerative disorder.